Kiromic BioPharma, Inc (KRBP)

Etorro trading 970x250
Kiromic BioPharma, Inc (KRBP) Logo

About Kiromic BioPharma, Inc

Kiromic BioPharma, Inc., a target discovery and gene editing company, focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. Its product portfolio include ALEXIS AIDT-1, an allogenic CAR cell product candidate targeting AIDT-1; ALEXIS AIDT-2 EOC, an allogenic CAR cell product candidate targeting AIDT-2; ALEXIS AIDT-2 MPM (malignant pleural mesothelioma), an allogenic CAR/NKT-Like cell product candidate targeting AIDT-2; and PD-1-AR, a check point inhibitor for solid tumors, as well as oral healthcare products, such as mouthwash. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. Address: 7707 Fannin, Houston, TX, United States, 77054

Kiromic BioPharma, Inc News and around…

Latest news about Kiromic BioPharma, Inc (KRBP) common stock and company :

61 Biggest Movers From Yesterday
04 Jan, 2022 FinancialContent

Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for ...

Diamond Equity Research Initiates Coverage on Kiromic BioPharma, Inc. (NASDAQ: KRBP)
22 Dec, 2021 Yahoo! Finance

NEW YORK, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Kiromic BioPharma, Inc. (NASDAQ:KRBP). The in-depth 24-page initiation report includes detailed information on the Kiromic BioPharma Inc.’s business model, services, industry, valuation, management, and risks. The full research report is available here. Highlights from the report include: Large Market Opportunity Diamo

Kiromic BioPharma Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
24 Nov, 2021 FinancialContent

Kiromic BioPharma Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

12 Health Care Stocks Moving In Friday's After-Market Session
08 Nov, 2021 FinancialContent

Gainers Kiromic BioPharma (NASDAQ:KRBP) shares increased by 5.26% to $3.0 during Friday's after-market session. The market value of ...

64 Biggest Movers From Yesterday
02 Nov, 2021 FinancialContent

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock ...

40 Stocks Moving In Monday's Mid-Day Session
01 Nov, 2021 FinancialContent

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
29 Oct, 2021 FinancialContent

Gainers OptiNose (NASDAQ:OPTN) stock rose 17.74% to $3.11 during Friday's pre-market session. The company's ...

12 Health Care Stocks Moving In Thursday's After-Market Session
28 Oct, 2021 FinancialContent

Gainers Bellerophon Therapeutics (NASDAQ:BLPH) shares moved upwards by 8.12% to $3.66 during Thursday's after-market ...

12 Health Care Stocks Moving In Thursday's Intraday Session
28 Oct, 2021 FinancialContent

Gainers Kiromic BioPharma (NASDAQ:KRBP) stock moved upwards by 21.62% to $2.25 during Thursday's regular session. ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
26 Oct, 2021 FinancialContent

Gainers Ocugen (NASDAQ:OCGN) shares increased by 26.44% to $11.81 during Tuesday's regular session. Trading volume ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
26 Oct, 2021 FinancialContent

Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market ...

12 Health Care Stocks Moving In Monday's After-Market Session
25 Oct, 2021 FinancialContent

Gainers Medpace Hldgs (NASDAQ:MEDP) shares moved upwards by 10.73% to $208.6 during Monday's after-market session. The market value ...

12 Health Care Stocks Moving In Monday's Intraday Session
25 Oct, 2021 FinancialContent

Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
25 Oct, 2021 FinancialContent

Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 28.64% to $2.47 during Monday's pre-market session. The ...

Kiromic BioPharma, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01, Company’s Phase 1 Cell Therapy Cancer V
25 Oct, 2021 FinancialContent

Kiromic, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01

Kiromic BioPharma, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01, Company’s Phase 1 Cell Therapy Cancer Vaccine Candidate for Solid Tumors
25 Oct, 2021 Yahoo! Finance

HOUSTON, October 25, 2021--Kiromic, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid Cancers
11 Oct, 2021 FinancialContent

Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital

35 Biggest Movers From Friday
11 Oct, 2021 FinancialContent

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s ...

28 Stocks Moving In Friday's Mid-Day Session
08 Oct, 2021 FinancialContent

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) ...

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Kiromic BioPharma Announces Chief Financial Officer Transition
06 Oct, 2021 FinancialContent

Kiromic BioPharma Announces Chief Financial Officer Transition

3 Penny Stocks Insiders Are Buying
13 Sep, 2021 FinancialContent

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

48 Biggest Movers From Yesterday
10 Sep, 2021 FinancialContent

Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and ...

35 Stocks Moving In Thursday's Mid-Day Session
09 Sep, 2021 FinancialContent

Gainers Gevo, Inc. (NASDAQ: GEVO) shares climbed 36.6% to $7.91. Chevron and Gevo announced intent to pursue sustainable aviation ...

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
20 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights
13 Aug, 2021 FinancialContent

Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights

Kiroma BioPharma, Inc. Investors: Company Investigated by the Portnoy Law Firm
29 Jul, 2021 FinancialContent

Investors can contact the law firm at no cost to learn more about recovering their losses

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
28 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Kiromic BioPharma, Inc (KRBP) is a NASDAQ Common Stock listed in , ,

970x250